Opendata, web and dolomites

INSPIRE SIGNED

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INSPIRE project word cloud

Explore the words cloud of the INSPIRE project. It provides you a very rough idea of what is the project "INSPIRE" about.

understand    animals    additionally    pharmacology    3rs    silico    technological    onset    toxicities    representing    secondments    changing    events    preclinical    local    innovative    scientists    expertise    hands    new    screening    reduce    balanced    laboratory    hence    attrition    exposure    drug    delivering    adverse    skills    scientific    integration    ing    prevalent    wp3    wp4    oncology    fail    unites    safety    generation    toxicity    providers    hospitals    structural    off    inspire    academic    stage    solutions    network    candidates    imaging    uses    15    wp2    indicates    combination    dynamic    feedback    spectroscopy    cv    training    hardware    unparalleled    platform    assays    exploration    humanized    detect    equip    transferable    mechanisms    regulators    validated    cardiomyocytes    vi    pharmacodynamic    mass    undesirable    vitro    sp    industry    functional    courses    pharmaceutical    wp1    multidisciplinary    clinical    thereby    create    adapt    collaborations    vision    screens    intersectoral    constitutes    teams    predictions    haemodynamics    vivo    exploring    companies    cardio    esrs    limitation    cardiovascular    software   

Project "INSPIRE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT ANTWERPEN 

Organization address
address: PRINSSTRAAT 13
city: ANTWERPEN
postcode: 2000
website: www.ua.ac.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 4˙021˙968 €
 EC max contribution 4˙021˙968 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT ANTWERPEN BE (ANTWERPEN) coordinator 768˙960.00
2    THE UNIVERSITY OF NOTTINGHAM UK (NOTTINGHAM) participant 606˙345.00
3    NOTOCORD SYSTEMS FR (LE PECQ) participant 549˙604.00
4    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 531˙239.00
5    INSTITUT NATIONAL DE RECHERCHE ENINFORMATIQUE ET AUTOMATIQUE FR (LE CHESNAY CEDEX) participant 274˙802.00
6    NCARDIA BV NL (LEIDEN) participant 265˙619.00
7    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) participant 263˙500.00
8    UCB BIOPHARMA SRL BE (BRUXELLES) participant 256˙320.00
9    BOEHRINGER INGELHEIM PHARMA GMBH &CO KG DE (INGELHEIM) participant 252˙788.00
10    TSE SYSTEMS GMBH DE (BAD HOMBURG VOR DER HOHE) participant 252˙788.00

Map

 Project objective

New drug candidates often have off-target effects resulting in adverse events, thus representing a major limitation for drug R&D. Safety Pharmacology (SP) aims to detect, understand and reduce undesirable pharmacodynamic effects early-on. Especially, cardiovascular (CV) toxicity is problematic, as it is the most prevalent reason for failure during preclinical development. Moreover, CV toxicity remains a key reason for drug attrition during clinical development and beyond. This indicates current SP screens fail to detect a number of (late-onset) functional or structural CV toxicities. Additionally, SP uses a significant number of laboratory animals, thereby creating opportunities for a better implementation of the 3Rs. The vision of INSPIRE is to advance and “inspire” SP by exploring new technological capabilities (WP1), addressing emerging CV concerns (WP2) and delivering new validated solutions for CV safety screening (WP3). To this end, INSPIRE unites expertise from academic teams, technology-providers, pharmaceutical companies, regulators and hospitals to create a European training platform for 15 Early Stage Researchers (ESRs). Key innovative aspects of INSPIRE include: i) in vitro humanized cardiomyocytes assays, ii) unparalleled in vivo hardware/software solutions, iii) in silico predictions of haemodynamics, iv) mass spectroscopy imaging of drug exposure, v) exploration of mechanisms of late-onset CV toxicity, as observed in cardio-oncology, and vi) early integration of feedback from industry and regulators. Overall, INSPIRE constitutes a multidisciplinary and intersectoral training programme (WP4) with a balanced combination of hands-on research training, intersectoral secondments, local courses and network-wide events on scientific and transferable skills, enabling future R&I collaborations. Hence, INSPIRE will equip the future generation of SP scientists with a wide range of scientific knowledge and the ability to adapt to a dynamic ever-changing industry.

 Deliverables

List of deliverables.
Start recruitment procedure Other 2020-02-27 15:24:01

Take a look to the deliverables list in detail:  detailed list of INSPIRE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INSPIRE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INSPIRE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

AIMed (2020)

Antimicrobial Integrated Methodologies for orthopaedic applications

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More